KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Dec 2024 value amounting to $17.6 million.

  • Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) rose 1.95% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year increase of 1.95%. This contributed to the annual value of $17.6 million for FY2024, which is 1.02% up from last year.
  • As of FY2024, Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $17.6 million, which was up 1.02% from $17.4 million recorded in FY2023.
  • Rigel Pharmaceuticals' 5-year Shares Outstanding (Weighted Average) high stood at $17.6 million for FY2024, and its period low was $16.9 million during FY2020.
  • For the 3-year period, Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $17.4 million, with its median value being $17.4 million (2023).
  • Data for Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY rose of 1.20% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Rigel Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $16.9 million in 2020, then increased by 1.20% to $17.1 million in 2021, then rose by 1.07% to $17.3 million in 2022, then climbed by 0.89% to $17.4 million in 2023, then climbed by 1.02% to $17.6 million in 2024.